Trouble in the neighborhood: How one type of chromosome abnormality is more common than previously thought A recent study by Dr. Vesna Najfeld and her team brings fresh insights into myelofibrosis (MF), a type of myeloproliferative neoplasm (MPN). Their work highlights the importance of closely tracking genetic changes over time and suggests that changes around… Read More »Trouble in the neighborhood: How one type of chromosome abnormality is more common than previously thought
A wedding with a cause: How Adam and Jenny transformed tradition into purpose When Jenny Applequist was diagnosed with a myeloproliferative neoplasm (MPN) in 2019, it marked the beginning of a transformative journey. “I felt a flood of emotions when I was first diagnosed,” Jenny shared. “I was still in denial for years.” Over time,… Read More »A wedding with a cause: How Adam and Jenny transformed tradition into purpose
Profile: Dr. Anandi Krishnan, PhDRutgers University Dr. Anandi Krishnan: A pioneer in collaborative MPN research Dr. Anandi Krishnan, PhD, believes that meaningful scientific breakthroughs don’t happen in isolation. In an academic world where scientific discovery often feels siloed, Dr. Anandi Krishnan’s new laboratory in the department of biomedical engineering at Rutgers University operates like a bustling… Read More »Dr. Anandi Krishnan, PhD Research Profile
The sweet dilemma: balancing sugar intake and cancer risk this halloween Over the last 30 years, our consumption of sugar-laden beverages and processed foods has skyrocketed (Ma et al., 2022). While sugar itself isn’t inherently carcinogenic, the conditions it creates—like inflammation and metabolic dysfunction—set the stage for cancer to thrive. Chronic inflammation plays a significant… Read More »October call out: Candy caution!
Profile: Dr. Robert Kralovics, PhDMedical University of Vienna Harnessing the Immune System: Dr. Robert Kralovics’ Groundbreaking MPN Research Dr. Robert Kralovics is known for his relentless focus on unraveling the mysteries of myeloproliferative neoplasms (MPNs) —a family of rare blood cancers. As he admits, “I’ve been told I’m absent-minded because if someone suddenly talks to… Read More »Dr. Robert Kralovics, PhD Research Profile
Do you know about mutations? Instructions: New genes and proteins are being discovered every year in the landscape of MPN research. Put your genetic know-how to the ultimate test with this advanced-level MPN crossword puzzle. Answers may include gene acronyms, mutations, and numbers, but no hyphens. You can find these answers below. Answers: Sources: Guglielmelli, P.,… Read More »Do you know your mutations? Genetics crossword
It is with a heavy heart that we announce the passing of Zhenya Senyak, who has died surrounded by his loving family in Asheville NC, after a long journey with illness. Those who have been in the MPN community for some time will recognize Zhenya’s passing as a watershed event. His dedication, resolve, and tireless… Read More »Remembering Zhenya Senyak
“This new work from Gaertner et al. is significant and potentially field-changing,” says Anandi Krishnan PhD from Rutgers University, commenting on the new Nature journal study. “This is especially relevant in the context of managing blood disorders such as MPNs.” The study does not mention ‘cancer’ or ‘myeloproliferation,’ yet its findings may be crucial… Read More »New Study Reveals On-Off Switch for Platelet Production
Profile: Marina Kremyanskaya MD, PhD Icahn School of Medicine, New York, NY, USA From Bench to Bedside: Dr. Marina Kremyanskaya’s Mission to Revolutionize MPN Treatment Downplaying a cure “It is an experimental treatment. There is no doubt about it,” Marina Kremyanskaya MD, PhD, states plainly about a new anti-cancer vaccine for patients with myeloproliferative neoplasms… Read More »Marina Kremyanskaya, MD, PhD Research Profile
